COVID-19 vaccine
-
October 7, 2021
Boosta-Palooza
VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event. -
September 22, 2021
Rounds: Hard conversations
-
August 30, 2021
VUMC nurse Shakeya Bean featured in national public service announcement about COVID vaccines
She sees patients who are struggling after a COVID infection. "It doesn't have to be this way," she said. -
August 10, 2021
Shared antibodies may push COVID-19 variants: VUMC study
Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells. -
August 5, 2021
Digital growth, improvements, vaccinations: Leadership Assembly takeaways
Vanderbilt University Medical Center completed its first full fiscal year of the COVID-19 era having achieved remarkable outcomes in digital health, growth and quality because of consistently strong performance from its workforce. -
July 27, 2021
Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study
A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020. -
July 26, 2021
Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study
An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.